# Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults

> **NCT01314911** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 716 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** Oseltamivir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01314911
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2017-11-18
- **Final completion:** 2017-11-18
- **Target enrollment:** 716 (ACTUAL)
- **Last updated:** 2019-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314911, "Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01314911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*